0001209191-17-029191.txt : 20170502
0001209191-17-029191.hdr.sgml : 20170502
20170502162027
ACCESSION NUMBER: 0001209191-17-029191
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170501
FILED AS OF DATE: 20170502
DATE AS OF CHANGE: 20170502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Masoudi Gerald
CENTRAL INDEX KEY: 0001641287
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 17805296
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
STREET 2: C/O CELGENE CORP
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-01
0
0000816284
CELGENE CORP /DE/
CELG
0001641287
Masoudi Gerald
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
1
0
0
Executive Vice President
Stock Option (right to buy)
124.06
2017-05-01
4
A
0
10245
0.00
A
2027-05-01
Common Stock
10245
10245
D
Restricted Stock Unit
2017-05-01
4
A
0
5180
0.00
A
Common Stock
5180
5180
D
Option is immediately exercisable and will vest in four equal annual installments commencing on May 1, 2018.
The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of April 15, 2015).
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units were issued pursuant to the Company's 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015) and will vest on May 1, 2020. Vested shares will be delivered to the reporting person on the vesting date.
Executive Vice President, General Counsel and Corporate Secretary
/s/ Peter N. Kellogg, Executive Vice President and Chief Financial Officer
2017-05-01